Batte Charles, Semulimi Andrew Weil, Mukisa John, Nakabuye Mariam, Nidoi Jasper, Mukunya David, Ratanshi Rosalind Parkes, Castelnuovo Barbara, Lamorde Mohammed, Meya David, Checkley William, Kalyesubula Robert, Siddharthan Trishul, Babigumira Joseph B
Department of Medicine, Lung Institute, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
PLoS One. 2024 Aug 8;19(8):e0306928. doi: 10.1371/journal.pone.0306928. eCollection 2024.
The presence of hypertension could reduce the health-related quality of life (HRQoL) of people with HIV (PWH). Yet, literature describing the HRQoL of PWH who have hypertension in Uganda is scarce making the design of locally adapted interventions cumbersome. In our study, we compared HRQoL scores of people with HIV with and without hypertension on long term antiretroviral therapy (ART) in Uganda.
We recruited 149 PWH with hypertension and 159 PWH without hypertension in the long-term ART cohort at an urban clinic in Kampala, Uganda. Data on socio-demographics were collected using an interviewer designed questionnaire while data on the World Health Organisation clinical stage viral load and CD4 count as well as ART duration were extracted from clinic electronic database and a generic EuroQol -5D- 5L (EQ-5D- 5L) and Medical Outcome Study (MOS-HIV) questionnaire used to collect HRQoL data. Data were summarized using descriptive statistics while inferential statistics were used to determine associations between key variables and HRQoL. Mann-Whitney U tests were used to compare HRQoL between groups of interest.
One hundred ninety (61.7%) participants were female. PWH who had hypertension were older (Mean ± SD: 53.7 ± 8.3 vs 49.9 ± 8.6, p value <0.001) than those without hypertension. Participants with hypertension had lower overall median health utility scores (0.71 (0.33-0.80) vs 0.80 (0.44-0.80), p value = 0.029) and mean physical health score (48.44 ± 10.17 vs 51.44 ± 9.65, p value < 0.001) as opposed to those without hypertension. Hypertension (p value = 0.023), high income status, >70,000 UGX, (p value = 0.044), disclosure of the HIV status of the participants to their partner (p value = 0.026), and current history of smoking (p value = 0.029) were associated with low HRQoL scores.
Among people with HIV, those with hypertension had lower HRQoL compared to those without. This calls for inclusion of quality-of-life assessment in the management of PWH who have been diagnosed with hypertension to identify those at risk and plan early interventions.
高血压的存在可能会降低艾滋病毒感染者(PWH)的健康相关生活质量(HRQoL)。然而,描述乌干达患有高血压的艾滋病毒感染者生活质量的文献很少,这使得设计适合当地情况的干预措施变得繁琐。在我们的研究中,我们比较了乌干达接受长期抗逆转录病毒治疗(ART)的有高血压和无高血压的艾滋病毒感染者的生活质量得分。
我们在乌干达坎帕拉的一家城市诊所的长期ART队列中招募了149名患有高血压的艾滋病毒感染者和159名无高血压的艾滋病毒感染者。使用访谈者设计的问卷收集社会人口统计学数据,同时从诊所电子数据库中提取世界卫生组织临床分期、病毒载量、CD4细胞计数以及ART持续时间的数据,并使用通用的欧洲五维健康量表-5D-5L(EQ-5D-5L)和医学结局研究(MOS-HIV)问卷收集生活质量数据。使用描述性统计对数据进行总结,同时使用推断性统计来确定关键变量与生活质量之间的关联。使用曼-惠特尼U检验比较感兴趣组之间的生活质量。
190名(61.7%)参与者为女性。患有高血压的艾滋病毒感染者比没有高血压的感染者年龄更大(平均±标准差:53.7±8.3岁对49.9±8.6岁,p值<0.001)。与没有高血压的参与者相比,患有高血压的参与者总体健康效用中位数得分较低(0.71(0.33-0.80)对0.80(0.44-0.80),p值=0.029),身体健 康平均得分较低(48.44±10.17对51.44±9.65,p值<0.001)。高血压(p值=0.023)、高收入状况(>70,000乌干达先令,p值=0.044)、参与者向其伴侣披露艾滋病毒感染状况(p值=0.026)以及当前吸烟史(p值=0.029)与低生活质量得分相关。
在艾滋病毒感染者中,患有高血压的人与没有高血压的人相比生活质量较低。这就要求在对已诊断患有高血压的艾滋病毒感染者的管理中纳入生活质量评估,以识别有风险的人并规划早期干预措施。